Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Koichiro Miyagawa"'
Autor:
Tsuyoshi Ueda, Shinji Oe, Akitoshi Yoneda, Yudai Koya, Satoru Nebuya, Koichiro Miyagawa, Yuichi Honma, Michihiko Shibata, Shohei Shimajiri, Masaru Harada
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract An 82‐year‐old man had been treated for lung adenocarcinoma and hepatocellular carcinoma (HCC). Contrast‐enhanced computed tomography examination showed swelling of the left adrenal gland, suggesting metastasis of lung adenocarcinoma,
Externí odkaz:
https://doaj.org/article/68ba585ead164743ab29b304cba6b7e7
Autor:
Kengo Yoshitomi, Yudai Koya, Koichiro Miyagawa, Yuki Maruno, Koki Yamaguchi, Ryuta Taniguchi, Koji Onitsuka, Yoshitaka Sakamoto, Shinji Oe, Masaru Harada
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2024 (2024)
A liver cyst is hepatic fluid-filled cavities often detected in clinical surveillances such as a health examination. Although the liver cyst is usually asymptomatic and observed without any therapeutic intervention, it can be symptomatic and needs tr
Externí odkaz:
https://doaj.org/article/bb4309b8d125404a9738425b1d1eb77f
Autor:
Tsuguru Hayashi, Tatsuyuki Watanabe, Michihiko Shibata, Shinsuke Kumei, Shinji Oe, Koichiro Miyagawa, Yuichi Honma, Masaru Harada
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Liver function is a most important prognostic factor in patients with liver cirrhosis. Also, portal hypertension is a fatal complication of liver cirrhosis and variceal treatment is indispensable. However, changes of liver functions after en
Externí odkaz:
https://doaj.org/article/6f48e1e50d0a45d99b8bba896e518e3a
Autor:
Tsuguru Hayashi, Michihiko Shibata, Shinji Oe, Koichiro Miyagawa, Yuichi Honma, Masaru Harada
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244370 (2020)
Background and aimLenvatinib has become a first line treatment for unresectable hepatocellular carcinoma (HCC). However, continued administration is impossible in many patients due to treatment resistance and severe adverse events. This study aimed t
Externí odkaz:
https://doaj.org/article/e596539edf7547bcbf5e2dc5d3bd171d
Autor:
Koichiro Miyagawa, Kenta Kajitani, Takahiro Makita, Kosuke Hideshima, Nobuhiko Shinohara, Shinji Oe, Yuichi Honma, Michihiko Shibata, Masaru Harada
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 18, p2525-2531, 7p
Autor:
Shinji OE, Shinsuke KUMEI, Tsukasa KARASUYAMA, Nobuhiko SHINOHARA, Kosuke HIDESHIMA, Akitoshi YONEDA, Koichiro MIYAGAWA, Yuichi HONMA, Michihiko SHIBATA, Masaru HARADA
Publikováno v:
Journal of UOEH. 45:123-127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bf85741776db5b021af3e7db6203ff3
https://doi.org/10.7888/juoeh.45.123
https://doi.org/10.7888/juoeh.45.123
Autor:
Koichiro, Miyagawa, Yu, Nakano, Akitoshi, Yoneda, Masashi, Kusanaga, Shinji, Oe, Yuichi, Honma, Michihiko, Shibata, Masaru, Harada
Publikováno v:
Journal of UOEH. 44:353-358
An 89-year-old man with polycystic liver disease (PCLD) received uncovered self-expandable metallic stent (SEMS) placement above the papilla for malignant biliary obstruction caused by cholangiocarcinoma. He developed cholangitis ten months later due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0abd6250dd1a3e1f2e8b9755379a6d
https://doi.org/10.7888/juoeh.44.353
https://doi.org/10.7888/juoeh.44.353
Autor:
Yuichi Honma, Michihiko Shibata, Kahori Morino, Yudai Koya, Tsuguru Hayashi, Noriyoshi Ogino, Masashi Kusanaga, Shinji Oe, Koichiro Miyagawa, Shintaro Abe, Akinari Tabaru, Masaru Harada
Publikováno v:
Digestive Diseases and Sciences. 68:685-698
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b88112eb9f3481f136204eb48fb0ae
https://doi.org/10.1007/s10620-022-07686-3
https://doi.org/10.1007/s10620-022-07686-3
Autor:
Hitoshi Nishio, Yuichi Honma, Keiichiro Kumamoto, Yasumichi Toki, Kahori Morino, Shinji Oe, Koichiro Miyagawa, Michihiko Shibata, Shintaro Abe, Yasuaki Tatsumi, Katsuya Ikuta, Hisao Hayashi, Masaru Harada
Publikováno v:
Kanzo. 63:151-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba7b3608f1d67d8c4d10d914f073570
https://doi.org/10.2957/kanzo.63.151
https://doi.org/10.2957/kanzo.63.151
Autor:
Satoru NEBUYA, Shinji OE, Yoshikazu HARADA, Yusuke TAKEUCHI, Akitoshi YONEDA, Yudai KOYA, Koichiro MIYAGAWA, Yuichi HONMA, Michihiko SHIBATA, Masaru HARADA
Publikováno v:
Journal of UOEH. 44(3)
Pancreatic neuroendocrine carcinoma (NEC) as classified in the World Health Organization (WHO) 2010 was reclassified in the WHO 2017 as either neuroendocrine tumor (NET) G3 or NEC. An accurate diagnosis based on the WHO 2017 classification is importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c882225d8b984895838c929ca72f9af
https://pubmed.ncbi.nlm.nih.gov/36089347
https://pubmed.ncbi.nlm.nih.gov/36089347